Breast Cancer Treatment Price Comparison in Delhi vs Turkey

Written by
Mustafa Çelik
Mustafa Çelik Liv Hospital Content Team
Medically reviewed by
Assoc. Prof. MD. Erkan Kayıkçıoğlu Assoc. Prof. MD. Erkan Kayıkçıoğlu TEMP. Cancer
...
Views
Read Time

Breast Cancer Treatment Cost: India Delhi vs Turkey

Meta Description

Compare Breast Cancer Treatment cost in India, Delhi vs Turkey: Save 40-70% in Turkey with advanced tech, JCI centers & seamless medical tourism packages. (128 characters)

Introduction & Clinical Importance

Breast cancer treatment involves surgery (lumpectomy/mastectomy), chemotherapy, radiation, hormone therapy, and targeted therapies like immunotherapy for HER2+ cases. Applied at stages I-IV to remove tumors, control spread, and prevent recurrence, it significantly improves survival but may impact quality of life via fatigue, lymphedema, or emotional distress.

In Delhi, high demand causes long waits (weeks-months) and elevated private costs. Turkey excels in medical tourism with high case volumes (thousands annually), JCI-accredited centers, and streamlined patient journeys.

Price Comparison: India Delhi vs Turkey

  • India (Delhi): USD 2,600-6,000 (public lower; private/insured up to 25,000 for complex cases), covering consults, surgery, basic chemo/radiation, 2-day stay.
  • Turkey: USD 6,900-10,300, includes initial tests, procedure, 3-day stay, meds, follow-up.

Turkey costs 40-70% more than basic Indian options but offers comprehensive packages; savings vs. home countries reach 70-80%.

Turkey’s Price Advantage & Superiorities

Competitive due to favorable exchange rates, lower ops costs, and tourism market. Advantages: short flights from Middle East/Europe, e-visas, English/Arabic/Russian support, all-inclusive packages with transfers/hotels. High oncology experience with 30,000+ annual chemo sessions.

Treatment Options, Modalities & Technologies

Options: surgical resection, chemo, radiation, biological/targeted therapies. Turkey uses robotic surgery, advanced imaging (MRI/PET-CT), IAEA-standard labs meeting global benchmarks. Delhi offers similar tech in top centers but more limited access elsewhere; both adhere to international protocols. Risks include infection (1-5%) or recurrence (10-30% stage-dependent).

Treatment Process: Patient Journey Comparison

  • Turkey: Online eval, quick tests, arrival-procedure-discharge in 5-7 days; coordinators, interpreters, transfers included.
  • Delhi: Longer waits, insurance hurdles.

Turkey’s process is faster (appointments in days), enhancing convenience.

Quality Assurance & Long-Term Follow-up

JCI/ISO-accredited Turkish centers feature specialist training (5-10+ years), multidisciplinary teams, strict infection controls. Follow-up via teleconsults, online portals; reports compatible for Delhi physicians post-return. Prices vary by condition/needs; obtain personalized quotes.

Trusted Worldwide
30
Years of
Experience
30 Years Badge

With patients from across the globe, we bring over three decades of medical

Get a Free Quote

Response within 2 hours during business hours

Clinics/branches
Was this content helpful?
Your feedback helps us improve.
What did you like?
Share more details about your experience.
You must give consent to continue.

Thank you!

Your feedback has been submitted successfully. Your input is valuable in helping us improve.

Our Doctors

Prof. MD. Binnur Pınarbaşı

Prof. MD. Binnur Pınarbaşı

Op. MD. Yücel Polat

Op. MD. Yücel Polat

Assoc. Prof. MD. Alper Canbay

Assoc. Prof. MD. Alper Canbay

MD. KAMRAN NAĞIYEV

MD. KAMRAN NAĞIYEV

MD. VÜQAR CEFEROV

Prof. MD. İsmet Alkış

Prof. MD. İsmet Alkış

Prof. MD. Kazım Özenç Minareci

Prof. MD. Kazım Özenç Minareci

Assoc. Prof. MD.  Tuğrul Yıldırım

Assoc. Prof. MD. Tuğrul Yıldırım

Spec. MD. Zümrüt Kocabey Sütçü

Spec. MD. Zümrüt Kocabey Sütçü

Spec. MD. REŞAD QUVALOV

Op. MD. Sevinç Bayrak

Op. MD. Sevinç Bayrak

Prof. MD. Levent Çelebi

Prof. MD. Levent Çelebi